BioCentury | Oct 26, 2017
Strategy

Capital call

...of artificial intelligence, and aging support 10 years • Use NHS cradle-to-grave data to develop predictive diagnostics...
BioCentury | Jul 30, 2015
Strategy

Genentech stays the course

...look for biomarkers and do prevalence work to really understand the patient populations with our predictive diagnostics...
BioCentury | Oct 31, 2013
Targets & Mechanisms

Personal factors

A multi-institute team collaborating with the FDA has determined why patients with a form of severe hemophilia rarely develop neutralizing antibodies against factor VIII replacement therapies. The team is also developing an algorithm to predict...
BioCentury | Apr 18, 2013
Cover Story

Targeting tankyrase

Researchers from the University of Oslo and Roche 's Genentech Inc. unit have developed several selective inhibitors of tankyrases TNKS and TNKS2 , two druggable targets in the otherwise hard-to-hit WNT pathway. 1,2 The University team's...
BioCentury | Feb 6, 2012
Financial News

Rosetta Genomics completes private placement of senior convertible debentures

Rosetta Genomics Ltd. (NASDAQ:ROSG), Rehovot, Israel Business: Diagnostic Date completed: 1/27/12 Type: Private placement of senior convertible debentures Raised: $1.8 million Placement agent: Aegis Capital Shares outstanding prior: 9.5 million Investor: Accredited investor Note: The...
BioCentury | Jun 16, 2008
Company News

Xceed Molecular Corp., Moffitt Cancer Center deal

...Xceed received exclusive, worldwide rights to the center’s multi-gene biomarker for colon cancer to develop predictive diagnostics...
BioCentury | Mar 31, 2008
Company News

HistoRx, Eli Lilly deal

...HistoRx has an option to commercialize the assays and reagents developed for clinical use as predictive diagnostics...
BioCentury | Jan 28, 2008
Company News

Clinical Data management update

...Clinical Data Inc. (NASDAQ:CLDA), Newton, Mass. Business: Supply/Service, Pharmacogenetics Hired: Meeta Patnaik as SVP of predictive diagnostics...
BioCentury | May 14, 2007
Company News

Avestha, Manipal AcuNova Ltd. deal

...develop molecular diagnostics for all indications and use systems biology to identify novel biomarkers for predictive diagnostics...
BioCentury | May 22, 2006
Strategy

Content meets conduit

...2006. But beyond the clinical diagnostics space, the company wants to be a player in predictive diagnostics...
...and doctor decide what to do about it. There’s a broader and deeper market for predictive diagnostics."...
...want to have the test at a much earlier age." Technically speaking, he added, developing predictive diagnostics...
Items per page:
1 - 10 of 14
BioCentury | Oct 26, 2017
Strategy

Capital call

...of artificial intelligence, and aging support 10 years • Use NHS cradle-to-grave data to develop predictive diagnostics...
BioCentury | Jul 30, 2015
Strategy

Genentech stays the course

...look for biomarkers and do prevalence work to really understand the patient populations with our predictive diagnostics...
BioCentury | Oct 31, 2013
Targets & Mechanisms

Personal factors

A multi-institute team collaborating with the FDA has determined why patients with a form of severe hemophilia rarely develop neutralizing antibodies against factor VIII replacement therapies. The team is also developing an algorithm to predict...
BioCentury | Apr 18, 2013
Cover Story

Targeting tankyrase

Researchers from the University of Oslo and Roche 's Genentech Inc. unit have developed several selective inhibitors of tankyrases TNKS and TNKS2 , two druggable targets in the otherwise hard-to-hit WNT pathway. 1,2 The University team's...
BioCentury | Feb 6, 2012
Financial News

Rosetta Genomics completes private placement of senior convertible debentures

Rosetta Genomics Ltd. (NASDAQ:ROSG), Rehovot, Israel Business: Diagnostic Date completed: 1/27/12 Type: Private placement of senior convertible debentures Raised: $1.8 million Placement agent: Aegis Capital Shares outstanding prior: 9.5 million Investor: Accredited investor Note: The...
BioCentury | Jun 16, 2008
Company News

Xceed Molecular Corp., Moffitt Cancer Center deal

...Xceed received exclusive, worldwide rights to the center’s multi-gene biomarker for colon cancer to develop predictive diagnostics...
BioCentury | Mar 31, 2008
Company News

HistoRx, Eli Lilly deal

...HistoRx has an option to commercialize the assays and reagents developed for clinical use as predictive diagnostics...
BioCentury | Jan 28, 2008
Company News

Clinical Data management update

...Clinical Data Inc. (NASDAQ:CLDA), Newton, Mass. Business: Supply/Service, Pharmacogenetics Hired: Meeta Patnaik as SVP of predictive diagnostics...
BioCentury | May 14, 2007
Company News

Avestha, Manipal AcuNova Ltd. deal

...develop molecular diagnostics for all indications and use systems biology to identify novel biomarkers for predictive diagnostics...
BioCentury | May 22, 2006
Strategy

Content meets conduit

...2006. But beyond the clinical diagnostics space, the company wants to be a player in predictive diagnostics...
...and doctor decide what to do about it. There’s a broader and deeper market for predictive diagnostics."...
...want to have the test at a much earlier age." Technically speaking, he added, developing predictive diagnostics...
Items per page:
1 - 10 of 14